China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (CR Sanjiu) is a state-controlled OTC pharmaceutical giant and the undisputed leader in China's cold, cough, and digestive tract TCM segments. Listed on the Shenzhen Stock Exchange (000999.SZ) and headquartered in Shenzhen, the company generated CNY 27.61 billion in annual revenue in 2025, with net profit surging 18.05% to CNY 3.367 billion
Core Business Areas
Industry Rankings
VerityRank Score
Based on market presence, financial scale, operational capacity, and brand strength.
Quick Facts
Headquarters
Shenzhen, Guangdong
Founded
1999
Employees
15,000+
Listing
Listed - SZSE (000999.SZ)
Categories
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: Official Website , CR Sanjiu Earnings Alert - Smartkarma, Annual Results Announcement 2024 - HKEXnews, ESG and Responsibility Report 2025 - CR Sanjiu